glto-s8.htm

As filed with the Securities and Exchange Commission on February 17, 2022

Registration No. 333-    

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-8

REGISTRATION STATEMENT

Under

The Securities Act of 1933

 

GALECTO, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

Delaware

 

37-1957007

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

75 State Street, Suite 100

Boston, Massachusetts, 02109

Ole Maaloes Vej 3

DK-2200 Copenhagen N

Denmark

(+45) 70 70 52 10

(Address of Principal Executive Offices)

Galecto, Inc. 2020 Equity Incentive Plan

(Full Title of the Plans)

The Corporation Trust Company

c/o Galecto, Inc.

1209 Orange Street

Wilmington, DC 19801

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

Edwin M. O’Connor

Goodwin Procter LLP

620 8th Avenue

New York, NY 10018

(212) 813-8800

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

 

 

 

 

 

 

Large accelerated filer

 

  

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

  

Smaller reporting company

 

 

 

 

 

 

 

 

  

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  

 

 

STATEMENT OF INCORPORATION BY REFERENCE

This Registration Statement registers additional securities of the same class as other securities for which a registration statement filed on Form S-8 (File No. 333-249852) of the Registrant is effective. The information contained in the Registration Statement is hereby incorporated by reference pursuant to General Instruction E.

 


 

 

 

Part II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 8.

Exhibits.

EXHIBIT INDEX

 

 

 

 

Exhibit

No.

  

Description

4.1

  

Amended and Restated Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, as filed with the Commission on November 4, 2020 (File No. 001-39655)).

 

 

4.2

  

Amended and Restated By-laws (Incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K, as filed with the Commission on November 4, 2020 (File No. 001-39655)).

 

 

4.3

  

Amended and Restated Investors’ Rights Agreement among the registrant and certain of its stockholders, dated September 25, 2020 (Incorporated by reference to Exhibit 4.2 to the registrant’s Registration Statement on Form S-1, as amended (File No. 333-249369)).

 

 

5.1*

  

Opinion of Goodwin Procter LLP.

 

 

23.1*

  

Consent of EY Godkendt Revisionspartnerselskab, Independent Registered Public Accounting Firm.

 

 

23.2*

  

Consent of Goodwin Procter LLP (included in Exhibit 5.1).

 

 

24.1*

  

Power of Attorney (included on signature page to this registration statement).

 

 

99.1

  

2020 Equity Incentive Plan and forms of award agreements thereunder (Incorporated by reference to Exhibit 10.2 to the Registrant’s Annual Report on Form 10-K, as filed with the Commission on March 29, 2021).

 

 

 

107*

 

Filing fee table.

 

 

*

Filed herewith.

 


 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Copenhagen, Denmark, on the 17th of February, 2022.

 

 

 

Galecto, Inc.

Date: February 17, 2022

 

By:

/s/ Hans T. Schambye, M.D., Ph.D.

 

 

 

Hans T. Schambye, M.D., Ph.D.

 

 

 

Chief Executive Officer and President

 

POWER OF ATTORNEY AND SIGNATURES

KNOW ALL BY THESE PRESENT, that each individual whose signature appears below hereby constitutes and appoints Hans T. Schambye and Jonathan Freve, and each of them, either of whom may act without the joinder of the other, as his or her true and lawful attorneys-in-fact and agents with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated below.

 

 

 

 

 

 

Name

  

Title

  

Date

 

 

 

/s/ Hans T. Schambye

Hans T. Schambye

  

President, Chief Executive Officer and Director

(Principal Executive Officer)

  

February 17, 2022

 

 

 

/s/ Jonathan Freve

Jonathan Freve

  

Chief Financial Officer (Principal

Financial Officer and Accounting Officer)

  

February 17, 2022

 

 

 

/s/ Carl Goldfischer, M.D

Carl Goldfischer, M.D.

  

Chairman

  

February 17, 2022

 

 

 

/s/ Jayson Dallas, M.D.

 

Director

 

February 17, 2022

Jayson Dallas, M.D.

 

 

 

 

 

 

 

 

 

/s/ Chau Q. Khuong

Chau Q. Khuong

  

Director

  

February 17, 2022

 

 

 

/s/ Søren Møller, Ph.D.

Søren Møller, Ph.D.

  

Director

  

February 17, 2022

 

 

 

/s/ Amit D. Munshi

Amit D. Munshi

  

Director

  

February 17, 2022

 

 

 

/s/ Anne Prener, M.D.

Anne Prener, M.D.

  

Director

  

February 17, 2022

 

 

 

/s/ David Shapiro, M.D.

David Shapiro, M.D.

  

Director

  

February 17, 2022

 

glto-ex51_7.htm

Exhibit 5.1

 

 

February 17, 2022

Galecto, Inc.

Ole Maaloes Vej 3

DK-2200 Copenhagen N

Denmark

Re: Securities Being Registered under Registration Statement on Form S-8

We have acted as counsel to you in connection with your filing of a Registration Statement on Form S-8 (the “Registration Statement”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”), on or about the date hereof relating to the registration of the offering by Galecto, Inc., a Delaware corporation (the “Company”) of 1,263,091 shares (the “Shares”) of the Company’s Common Stock, $0.0001 par value per share (“Common Stock”), that may be issued pursuant to the Company’s 2020 Equity Incentive Plan (collectively, the “Plans”).

We have reviewed such documents and made such examination of law as we have deemed appropriate to give the opinions set forth below. We have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinion set forth below, on certificates of officers of the Company.

The opinion set forth below is limited to the Delaware General Corporation Law.

For purposes of the opinion set forth below, we have assumed that no event occurs that causes the number of authorized shares of Common Stock available for issuance by the Company to be less than the number of then unissued Shares.

Based on the foregoing, we are of the opinion that the Shares have been duly authorized and, upon issuance and delivery against payment therefor in accordance with the terms of the Plans, will be validly issued, fully paid and nonassessable.

We hereby consent to the inclusion of this opinion as Exhibit 5.1 to the Registration Statement. In giving our consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.

 

 

Very truly yours,

 

/S/ GOODWIN PROCTER LLP

 

GOODWIN PROCTER LLP

 

 

glto-ex231_6.htm

Exhibit 23.1

 

 

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2020 Equity Incentive Plan of Galecto, Inc. of our report dated February 17, 2022, with respect to the consolidated financial statements of Galecto, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.  

 

/s/ EY Godkendt Revisionspartnerselskab

 

Copenhagen, Denmark

 

February 17, 2022

 

 

 

glto-exfilingfees_66.htm

 

EXHIBIT 107

 

Calculation of Filing Fee Table

 

Form S-8

(Form Type)

 

Galecto, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1 - Newly Registered Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered(1)(2)

Proposed Maximum Offering Price Per Share(3)

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Equity

Common stock, $0.00001 par value per share

Rule 457(c) and Rule 457(h)

32,118

$3.24

$104,062.32

0.0000927

$9.65

Equity

Common stock, $0.00001 par value per share

Rule 457(c) and Rule 457(h)

200,000

$2.07

$414,000.00

0.0000927

$38.38

Equity

Common stock, $0.00001 par value per share

Rule 457(c) and Rule 457(h)

1,030,973

$2.11

$2,175,353.03

0.0000927

$201.66

Total Offering Amounts

 

 

 

$2,693,415.35

Total Fee Offsets

 

 

 

$-

Net Fee Due

 

 

 

$249.69

 

(1)

Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock which become issuable under the 2020 Plan by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of common stock. Pursuant to Rule 416(c) under the Securities Act, this Registration Statement shall also cover an indeterminate amount of interests to be offered or sold pursuant to the employee benefit plans described herein.


(2)

The aggregate 1,263,091 shares of common stock, par value $0.00001 per share (“Common Stock”), to be registered represents an automatic increase to the number of shares available for issuance under the registrant’s 2020 Equity Incentive Plan (the “2020 Plan”), effective as of January 1, 2022. Shares available for issuance under the 2020 Plan were previously registered on Form S-8 registration statements filed with the Securities and Exchange Commission on November 4, 2020 (Registration No. 333-249852) and March 29, 2021 (Registration No. 333-254805). The Common Stock to be registered consists of (i) 32,118 shares granted under the 2020 Plan on January 5, 2022, (ii) 200,000 shares granted under the 2020 Plan on February 15, 2022 and (iii) 1,030,973 shares which may hereafter be granted under the 2020 Plan.  

(3)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457 of the Securities Act, and based on $2.11 per share, which is the average of the high and low sales prices of the Registrant’s common stock, as reported on the Nasdaq Global Select Market on February 11, 2022, which is a date within five business days prior to the filing of this registration statement.